...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: TNBC no longer active?

You could be right on that Jonzobot.  It would be interesting to see what the response is to Koo's inquiry. I do find it interesting though that at the last Zenith AGM Don was talking about the huge bucks that were paid up for Trodelvy and saying "...we're not there yet but...." and now he is changing his tune. Seems to be an all too common theme with his "leadership"

Share
New Message
Please login to post a reply